Express News | Novartis innovates PNH oral monotherapy Feheda (ipcopam hydrochloride capsules) approved in China
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
Express News | Novartis's innovative drug for rare diseases has been approved domestically. It is the first oral monotherapy for PNH treatment in adults
Gilead Sciences To Go Ex-Dividend On June 14th, 2024 With 0.77 USD Dividend Per Share
April 27th - $Gilead Sciences(GILD.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.77 USD dividend per share on June 27th, 2024. The ex-div
Pfizer Options Spot-On: On April 26th, 118.91K Contracts Were Traded, With 3.21 Million Open Interest
On April 26th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 118.91K options for the day, of which put options accounted for 37.64% of the total transactions, and call